» Articles » PMID: 16185234

Short Communication: Impact of Long-term (14 Years) Bi-annual Ivermectin Treatment on Wuchereria Bancrofti Microfilaraemia

Overview
Date 2005 Sep 28
PMID 16185234
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Ivermectin has been and continues to be extensively used to control onchocerciasis in areas of hyper and mesoendemicity within the African Programme of Onchocerciasis Control. As programmes to eliminate lymphatic filariasis (LF) caused by Wuchereria bancrofti expand, areas of coendemicity with onchocerciasis will be incorporated into LF programmes. This study reports that in villages which were hyperendemic for onchocerciasis after some 14 years of treatment with ivermectin, no W. bancrofti could be detected in a population of 1210 individuals whilst in adjacent villages a prevalence of around 3% was found. Despite the long period of ivermectin treatment Mansonella perstans did not appear to respond to ivermectin in this setting.

Citing Articles

Importance of ivermectin to human onchocerciasis: past, present, and the future.

Cupp E, Mackenzie C, Unnasch T Res Rep Trop Med. 2019; 2:81-92.

PMID: 30881181 PMC: 6415580. DOI: 10.2147/RRTM.S19477.


Inflammatory and regulatory CCL and CXCL chemokine and cytokine cellular responses in patients with patent Mansonella perstans filariasis.

Wangala B, Gantin R, Vossberg P, Vovor A, Poutouli W, Komlan K Clin Exp Immunol. 2018; 196(1):111-122.

PMID: 30561772 PMC: 6422653. DOI: 10.1111/cei.13251.


Progress on elimination of lymphatic filariasis in Sierra Leone.

Koroma J, Sesay S, Conteh A, Paye J, Bah M, Sonnie M Parasit Vectors. 2018; 11(1):334.

PMID: 29866207 PMC: 5987388. DOI: 10.1186/s13071-018-2915-4.


Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.

Ahorlu C, Koka E, Adu-Amankwah S, Otchere J, de Souza D BMC Public Health. 2018; 18(1):238.

PMID: 29433461 PMC: 5809858. DOI: 10.1186/s12889-018-5157-7.


Phase III Clinical Trial to Evaluate Ivermectin in the Reduction of infection in the Brazilian Amazon.

Basano S, Camargo J, Fontes G, Pereira A, Medeiros J, de Oliveira Laudisse M Am J Trop Med Hyg. 2018; 98(3):786-790.

PMID: 29313486 PMC: 5930903. DOI: 10.4269/ajtmh.17-0698.